• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The association between white matter hyperintensities and amyloid and tau deposition.脑白质高信号与淀粉样蛋白和tau 沉积的关系。
Neuroimage Clin. 2023;38:103383. doi: 10.1016/j.nicl.2023.103383. Epub 2023 Mar 20.
2
Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.脑淀粉样蛋白沉积与脑白质高信号纵向变化的关系。
Alzheimers Res Ther. 2024 Mar 7;16(1):50. doi: 10.1186/s13195-024-01417-8.
3
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).早发性阿尔茨海默病患者的脑白质高信号高于认知正常和早发性非 AD 同龄患者:早发性阿尔茨海默病纵向研究 (LEADS)。
Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S89-S97. doi: 10.1002/alz.13402. Epub 2023 Jul 25.
4
Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.区域脑白质高信号与认知正常和轻度认知障碍老年人的阿尔茨海默病生物标志物。
J Alzheimers Dis. 2023;92(1):323-339. doi: 10.3233/JAD-220846.
5
Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.将脑白质高信号与阿尔茨海默病的区域性皮质变薄、淀粉样蛋白沉积和突触密度丧失联系起来。
Alzheimers Dement. 2024 Jun;20(6):3931-3942. doi: 10.1002/alz.13845. Epub 2024 Apr 22.
6
Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?基于 Fazekas 视觉评估量表的脑白质高信号能反映人群中的阿尔茨海默病病理吗?
Alzheimers Res Ther. 2024 Jul 10;16(1):157. doi: 10.1186/s13195-024-01525-5.
7
White matter hyperintensities: relationship to amyloid and tau burden.脑白质高信号:与淀粉样蛋白和 tau 负担的关系。
Brain. 2019 Aug 1;142(8):2483-2491. doi: 10.1093/brain/awz162.
8
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.脑白质高信号和淀粉样蛋白与轻度认知障碍个体的内嗅皮层体积均相关。
Alzheimers Dement. 2013 Oct;9(5 Suppl):S124-31. doi: 10.1016/j.jalz.2012.11.009. Epub 2013 Jan 30.
9
White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition.脑白质高信号模式:与共病、淀粉样蛋白和认知的关联。
Alzheimers Res Ther. 2024 Apr 1;16(1):67. doi: 10.1186/s13195-024-01435-6.
10
White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.临床前阿尔茨海默病的脑白质高信号与脑脊液阿尔茨海默病生物标志物。
Neurology. 2020 Mar 3;94(9):e950-e960. doi: 10.1212/WNL.0000000000008864. Epub 2019 Dec 30.

引用本文的文献

1
Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers.与传统的β-淀粉样蛋白和 Tau 蛋白生物标志物相比,评估氧化脂质对阿尔茨海默病连续体认知指标和白质高信号的预测价值。
Mol Neurobiol. 2025 Jul 16. doi: 10.1007/s12035-025-05185-w.
2
Onset ages of cerebrovascular disease and amyloid and effects on cognition in risk-enriched cohorts.高危人群队列中脑血管疾病和淀粉样蛋白的发病年龄及其对认知的影响。
Brain Commun. 2025 Apr 19;7(3):fcaf158. doi: 10.1093/braincomms/fcaf158. eCollection 2025.
3
Spatial-temporal interactions between white matter hyperintensities and multiple pathologies across the Alzheimer's disease continuum.阿尔茨海默病连续体中白质高信号与多种病理之间的时空相互作用。
Alzheimers Dement. 2025 Apr;21(4):e70098. doi: 10.1002/alz.70098.
4
Does white matter and vascular injury from repetitive head impacts lead to a novel pattern on T2 FLAIR MRI? A hypothesis proposal and call for research.重复性头部撞击导致的白质和血管损伤会在T2 FLAIR磁共振成像上呈现出一种新的模式吗?一项假设提议及研究呼吁。
Alzheimers Dement. 2025 Mar;21(3):e70085. doi: 10.1002/alz.70085.
5
Imaging markers of cerebral small vessel disease are associated with Alzheimer's disease: a systematic review and meta-analysis.脑小血管病的影像学标志物与阿尔茨海默病相关:一项系统评价和荟萃分析。
Front Aging Neurosci. 2025 Jan 28;17:1498636. doi: 10.3389/fnagi.2025.1498636. eCollection 2025.
6
Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review.脑淀粉样血管病的血浆生物标志物及其对淀粉样相关影像学异常的影响:综述
J Clin Med. 2025 Feb 7;14(4):1070. doi: 10.3390/jcm14041070.
7
Association of white matter hyperintensities with cognitive decline and neurodegeneration.脑白质高信号与认知衰退及神经退行性变的关联
Front Aging Neurosci. 2024 Sep 12;16:1412735. doi: 10.3389/fnagi.2024.1412735. eCollection 2024.
8
Neuroimaging and biofluid biomarkers across race and ethnicity in older adults across the spectrum of cognition.神经影像学和生物流体生物标志物在认知谱中老年人群体中的种族和民族差异。
Ageing Res Rev. 2024 Nov;101:102507. doi: 10.1016/j.arr.2024.102507. Epub 2024 Sep 19.
9
Pilot implementation of the revised criteria for staging of Alzheimer's disease by the Alzheimer's Association Workgroup in a tertiary memory clinic.阿尔茨海默病协会工作组在三级记忆诊所中对阿尔茨海默病分期修订标准的初步实施。
Alzheimers Dement. 2024 Nov;20(11):7831-7846. doi: 10.1002/alz.14245. Epub 2024 Sep 17.
10
Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis.脑血管成像生物标志物在检测脑淀粉样血管病中的作用。
Alzheimers Dement. 2024 Oct;20(10):7220-7231. doi: 10.1002/alz.14207. Epub 2024 Sep 1.

脑白质高信号与淀粉样蛋白和tau 沉积的关系。

The association between white matter hyperintensities and amyloid and tau deposition.

机构信息

Laboratory of NeuroImaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Alzheimer's Disease Research Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

出版信息

Neuroimage Clin. 2023;38:103383. doi: 10.1016/j.nicl.2023.103383. Epub 2023 Mar 20.

DOI:10.1016/j.nicl.2023.103383
PMID:36965457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10060905/
Abstract

White matter hyperintensities (WMHs) frequently occur in Alzheimer's Disease (AD) and have a contribution from ischemia, though their relationship with β-amyloid and cardiovascular risk factors (CVRFs) is not completely understood. We used AT classification to categorize individuals based on their β-amyloid and tau pathologies, then assessed the effects of β-amyloid and tau on WMH volume and number. We then determined regions in which β-amyloid and WMH accumulation were related. Last, we analyzed the effects of various CVRFs on WMHs. As secondary analyses, we observed effects of age and sex differences, atrophy, cognitive scores, and APOE genotype. PET, MRI, FLAIR, demographic, and cardiovascular health data was collected from the Alzheimer's Disease Neuroimaging Initiative (ADNI-3) (N = 287, 48 % male). Participants were categorized as A + and T + if their Florbetapir SUVR and Flortaucipir SUVR were above 0.79 and 1.25, respectively. WMHs were mapped on MRI using a deep convolutional neural network (Sepehrband et al., 2020). CVRF scores were based on history of hypertension, systolic and diastolic blood pressure, pulse rate, respiration rate, BMI, and a cumulative score with 6 being the maximum score. Regression models and Pearson correlations were used to test associations and correlations between variables, respectively, with age, sex, years of education, and scanner manufacturer as covariates of no interest. WMH volume percent was significantly associated with global β-amyloid (r = 0.28, p < 0.001), but not tau (r = 0.05, p = 0.25). WMH volume percent was higher in individuals with either A + or T + pathology compared to controls, particularly within in the A+/T + group (p = 0.007, Cohen's d = 0.4, t = -2.5). Individual CVRFs nor cumulative CVRF scores were associated with increased WMH volume. Finally, the regions where β-amyloid and WMH count were most positively associated were the middle temporal region in the right hemisphere (r = 0.18, p = 0.002) and the fusiform region in the left hemisphere (r = 0.017, p = 0.005). β-amyloid and WMH have a clear association, though the mechanism facilitating this association is still not fully understood. The associations found between β-amyloid and WMH burden emphasizes the relationship between β-amyloid and vascular lesion formation while factors like CVRFs, age, and sex affect AD development through various mechanisms. These findings highlight potential causes and mechanisms of AD as targets for future preventions and treatments. Going forward, a larger emphasis may be placed on β-amyloid's vascular effects and the implications of impaired brain clearance in AD.

摘要

脑白质高信号(WMHs)在阿尔茨海默病(AD)中经常出现,与缺血有关,尽管其与β-淀粉样蛋白和心血管危险因素(CVRFs)的关系尚未完全清楚。我们使用 AT 分类法根据β-淀粉样蛋白和 tau 病理学对个体进行分类,然后评估β-淀粉样蛋白和 tau 对 WMH 体积和数量的影响。然后确定β-淀粉样蛋白和 WMH 积累相关的区域。最后,我们分析了各种 CVRFs 对 WMHs 的影响。作为次要分析,我们观察了年龄和性别差异、萎缩、认知评分和 APOE 基因型的影响。正电子发射断层扫描(PET)、磁共振成像(MRI)、FLAIR、人口统计学和心血管健康数据来自阿尔茨海默病神经影像学倡议(ADNI-3)(N = 287,48%为男性)。如果 Florbetapir SUVR 和 Flortaucipir SUVR 高于 0.79 和 1.25,参与者分别被归类为 A+和 T+。使用深度卷积神经网络(Sepehrband 等人,2020 年)在 MRI 上绘制 WMHs。CVRF 评分基于高血压史、收缩压和舒张压、脉搏率、呼吸率、BMI 和最高得分为 6 的累积评分。回归模型和 Pearson 相关性分别用于测试变量之间的关联和相关性,其中年龄、性别、受教育年限和扫描仪制造商作为无兴趣的协变量。WMH 体积百分比与全球β-淀粉样蛋白显著相关(r = 0.28,p < 0.001),但与 tau 无关(r = 0.05,p = 0.25)。与对照组相比,无论 A+还是 T+病理个体的 WMH 体积百分比都更高,尤其是在 A+/T+组中(p = 0.007,Cohen's d = 0.4,t = -2.5)。个体 CVRFs 或累积 CVRF 评分与 WMH 体积增加无关。最后,β-淀粉样蛋白和 WMH 计数相关性最强的区域是右半球的颞中区域(r = 0.18,p = 0.002)和左半球的梭状回区域(r = 0.017,p = 0.005)。β-淀粉样蛋白和 WMH 之间存在明确的关联,但促进这种关联的机制仍不完全清楚。在β-淀粉样蛋白和 WMH 负担之间发现的关联强调了β-淀粉样蛋白与血管病变形成之间的关系,而 CVRFs、年龄和性别等因素则通过各种机制影响 AD 的发展。这些发现突出了 AD 的潜在原因和机制,为未来的预防和治疗提供了目标。展望未来,可能会更加重视β-淀粉样蛋白的血管作用以及 AD 中脑清除能力受损的影响。